Advertisement Large retrospective analysis may prompt prospective studies How to talk about lifetime risk, treatment goals, Lp(a) testing, statin skepticism and more Robust signal from observational study raises prospect of a long-sought medical therapy Retrospective analysis finds lower mortality rates, fewer hospital visits among patients with Type 1 diabetes using GLP-1 Therapies Study shows significantly reduced risk of mortality and disease complications in patients receiving GLP-1 agonists Observational evidence of neuroprotection with GLP-1 receptor agonists and SGLT-2 inhibitors Study is first to show reduction in autoimmune disease with the common diabetes and obesity drugs Surgical intervention linked to increased lifespan and reduced complications
The response was dose-dependent, with higher doses producing slightly more fat loss, though the dose-response curve flattened at higher levels (Thompson et al., 2004)
Cc nghin cu cho thy ALCAR c th c li cho nhng ngi mc bnh thoi ha thn kinh Propionyl-L-Carnitine: y l loi ph hp nht h tr cc vn v tun hon, chng hn nh bnh mch mu ngoi bin v huyt p cao
Some of that pitch is grounded in real biology
Smaller, structured meals are your friend here
